Trilipix and Nerve compression - a phase IV clinical study of FDA data

Summary:

Nerve compression is reported as a side effect among people who take Trilipix (choline fenofibrate), especially for people who are female, 50-59 old, also take Diazepam, and have Asthma.

The phase IV clinical study analyzes which people have Nerve compression when taking Trilipix. It is created by eHealthMe based on reports of 5,551 people who have side effects when taking Trilipix from the FDA, and is updated regularly.

What is Trilipix?

Trilipix has active ingredients of choline fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 5,915 Trilipix users. Check the latest studies of Trilipix.

What is Nerve compression?

Nerve compression is found to be associated with 799 drugs and 675 conditions by eHealthMe. Check the latest studies of Nerve compression.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 04, 2026

5,551 people reported to have side effects when taking Trilipix.
Among them, 12 people (0.22%) have Nerve compression.

Among these 12 people:

What is the gender of people who have Nerve compression when taking Trilipix? *

female: 100 %
male: 0.0 %

What is the age of people who have Nerve compression when taking Trilipix? *

What are other drugs people take besides Trilipix? *

What are other side effects people have besides Nerve compression? *

Malaise (a feeling of general discomfort or uneasiness): 6 people, 50.00%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 6 people, 50.00%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 5 people, 41.67%
Dyspnea (difficult or laboured breathing): 5 people, 41.67%
Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall): 5 people, 41.67%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 5 people, 41.67%
Ankylosing Spondylitis (type of arthritis affecting the spine): 5 people, 41.67%
Weight Decreased: 5 people, 41.67%
Indigestion: 3 people, 25.00%
Migraine (headache): 3 people, 25.00%

What are the existing conditions these people have? *

Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 5 people, 41.67%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 5 people, 41.67%
Asthma: 5 people, 41.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 33.33%
Osteoporosis (bones weak and more likely to break): 3 people, 25.00%
High Blood Pressure: 2 people, 16.67%
Diabetes: 2 people, 16.67%
Depression: 2 people, 16.67%
Stress And Anxiety: 1 person, 8.33%
Sleep Disorder: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Trilipix and have Nerve compression?

- Check whether Nerve compression is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Trilipix:

Trilipix (5,915 reports)

Browse all side effects of Trilipix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nerve compression:

Nerve compression (799 drugs)

Browse all the conditions that are associated with Nerve compression:

Nerve compression (675 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on choline fenofibrate (the active ingredients of Trilipix) and Trilipix (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.